Cargando…

The Impact of Intrapericardial versus Intrapleural HeartMate 3 Pump Placement on Clinical Outcomes

BACKGROUND: The integrated design of the HeartMate 3 (Abbott Laboratories, Chicago, IL, USA) affords flexibility to place the pump within the pericardium or thoracic cavity. We sought to determine whether the presence of a left ventricular assist device (LVAD) in either location has a meaningful imp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salna, Michael, Ning, Yuming, Kurlansky, Paul, Yuzefpolskaya, Melana, Colombo, Paolo C., Naka, Yoshifumi, Takeda, Koji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society for Thoracic and Cardiovascular Surgery 2022
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178299/ https://www.ncbi.nlm.nih.gov/pubmed/35478180 http://dx.doi.org/10.5090/jcs.21.148

Ejemplares similares

Role of left atrial appendage occlusion in patients with HeartMate 3
por: Melehy, Andrew, et al.
Publicado: (2021)

Influence of Atrial Fibrillation on Functional Tricuspid Regurgitation in Patients With HeartMate 3
por: Hayashi, Hideyuki, et al.
Publicado: (2021)

Does lateral approach preserve the right ventricular function after HeartMate 3 insertion?
por: Hayashi, Hideyuki, et al.
Publicado: (2023)

Recurrent outflow graft compression of HeartMate3: When the left ventricular assist device sticks to the rib
por: Lotan, Dor, et al.
Publicado: (2022)

Electrostatic Discharge Causing Pump Shutdown in HeartMate 3
por: Najjar, Emil, et al.
Publicado: (2021)

Intraoperative pump thrombosis (PT) in HeartMate (HM) III
por: Karuppiah, Sathappan, et al.
Publicado: (2022)

Principles of HeartMate II Implantation to Avoid Pump Malposition and Migration
por: Adamson, Robert M, et al.
Publicado: (2015)

Characteristics and Outcomes of Patients With a Left Ventricular Assist Device With Coronavirus Disease-19
por: Sobol, Irina, et al.
Publicado: (2020)

Prevalence, Predictors, and Prognostic Value of Residual Tricuspid Regurgitation in Patients With Left Ventricular Assist Device
por: Nakanishi, Koki, et al.
Publicado: (2018)

Insights Into the Low Rate of In-Pump Thrombosis With the HeartMate 3: Does the Artificial Pulse Improve Washout?
por: Fang, Peng, et al.
Publicado: (2022)

Efficacy of Intrapleural or Intrapericardial Injection of Single Bevacizumab in the Treatment of Lung Cancer-Mediated Malignant Effusion
por: He, Dongyun, et al.
Publicado: (2022)

Left ventricular assist device exchange from HeartMate II to HeartMate 3 in an Asian patient—a case report and literature review
por: Chang, Hsiao-Huang, et al.
Publicado: (2023)

Validation of non‐invasive ramp testing for HeartMate 3
por: Najjar, Emil, et al.
Publicado: (2020)

The History of Durable Left Ventricular Assist Devices and Comparison of Outcomes: HeartWare, HeartMate II, HeartMate 3, and the Future of Mechanical Circulatory Support
por: Berardi, Cecilia, et al.
Publicado: (2022)

Infectious complications in patients with ventricular assist device HeartMate II
por: Konarik, M, et al.
Publicado: (2013)

HeartMate 3 Explantation Using Felt Plug for Ventriculotomy Occlusion
por: Medina, Melissa, et al.
Publicado: (2023)

HeartMate 3 biventricular support exceeding 4.5 years
por: Gasparovic, Hrvoje, et al.
Publicado: (2023)

Perioperative onset of acquired von Willebrand syndrome: Comparison between HVAD, HeartMate II and on-pump coronary bypass surgery
por: Feldmann, Christina, et al.
Publicado: (2017)

Infiltrative Cardiomyopathies
por: Bejar, David, et al.
Publicado: (2015)

Successful Pediatric Mechanical Thrombectomy for HeartMate 3-Related Intracranial Thromboembolism
por: Proulx, Catherine, et al.
Publicado: (2022)

HeartMate III as a Bridge to Transplantation in an Adolescent With Failed Fontan Circulation
por: Marey, Gamal, et al.
Publicado: (2019)

Feasibility of Mediastinal Radiation Use in HeartMate 3 LVAD Recipients with Cancer
por: Butt, Nausharwan, et al.
Publicado: (2023)

Hemocompatibility and hemodynamic comparison of two centrifugal LVADs: HVAD and HeartMate3
por: Gil, Antonio, et al.
Publicado: (2023)

Successful Use of Arteriovenous Graft for Hemodialysis Access After Left Ventricular Assist Device Placement
por: Toma, Katherine, et al.
Publicado: (2021)

Recurrent Early Thrombus Formation in HeartMate II Left Ventricular Assist Device
por: Capoccia, Massimo, et al.
Publicado: (2013)

Twisting and constriction of a HeartMate II driveline in the area of a repair site
por: Maier, Sven, et al.
Publicado: (2020)

HeartMate 3 Implantation via Only Left Thoracotomy: A Case Report
por: Jang, Mi Young, et al.
Publicado: (2023)

When to use central mechanical support devices
por: Salna, Michael, et al.
Publicado: (2020)

Plasma Trimethylamine-N-oxide and impaired glucose regulation: Results from The Oral Infections, Glucose Intolerance and Insulin Resistance Study (ORIGINS)
por: Roy, Sumith, et al.
Publicado: (2020)

Haemolysis as a first sign of thromboembolic event and acute pump thrombosis in patients with the continuous-flow left ventricular assist device HeartMate II
por: Akin, S., et al.
Publicado: (2015)

The difference between cystatin C‐ and creatinine‐based assessment of kidney function in acute heart failure
por: Pinsino, Alberto, et al.
Publicado: (2022)

Accuracy of Doppler blood pressure measurement in HeartMate 3 ventricular assist device patients
por: Li, Song, et al.
Publicado: (2020)

Ruptured hemorrhagic bulla in a patient with a HeartMate 3 treated with an Amplatzer device
por: daSilva-deAbreu, Adrian, et al.
Publicado: (2021)

Correction to: Twisting and constriction of a HeartMate II driveline in the area of a repair site
por: Maier, Sven, et al.
Publicado: (2021)

Do age and functional dependence affect outcomes of simultaneous heart–kidney transplantation?
por: Feng, Iris, et al.
Publicado: (2023)

Primary results of long‐term outcomes in the MOMENTUM 3 pivotal trial and continued access protocol study phase: a study of 2200 HeartMate 3 left ventricular assist device implants
por: Mehra, Mandeep R., et al.
Publicado: (2021)

Thromboembolic stroke in patients with a HeartMate-II left ventricular assist device – the role of anticoagulation
por: van den Bergh, Walter M., et al.
Publicado: (2015)

Totally percutaneous endovascular repair of HeartMate 3 ventricular assistive device outflow graft pseudoaneurysm
por: Balceniuk, Mark D., et al.
Publicado: (2020)

Comparing short‐term outcome after implantation of the HeartWare® HVAD® and the Abbott® HeartMate 3®
por: Schramm, Rene, et al.
Publicado: (2020)

Six‐month outcomes in postapproval HeartMate3 patients: A single‐center US experience
por: Bansal, Aditya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tqghc5dl4iepeht2m0vfbbjdl6